Results 61 to 70 of about 10,542 (115)

Intensity-modulated radiation therapy from 70Gy to 80Gy in prostate cancer: six- year outcomes and predictors of late toxicity

Radiation Oncology, 2017
Objective To report grade ≥2 overall late rectal and urinary toxicities in patients (pts) with prostate cancer treated by intensity-modulated radiotherapy (IMRT) at 3 dose-levels.
Maria Jolnerovski, Julia Salleron, Véronique Beckendorf, Didier Peiffert, Anne-Sophie Baumann, Valérie Bernier, Sandrine Huger, Vincent Marchesi, Ciprian Chira   +8 more
doaj   +1 more source

Can inter-observer consistency be achieved in the laparoscopic assessment of the peritoneal carcinomatosis index score in peritoneal metastasis? A pilot study

Pleura and Peritoneum
The main prognostic factor for peritoneal metastasis (PM) is the complete resection of the disease during cytoreductive surgery. Accurate patient selection is therefore essential for determining eligibility for this type of surgery.
Astruc Audrey, Seegers Valérie, Dumont Frederic, Loaec Cécile, Thibaudeau Emilie, Bourgin Charlotte, Wernert Romuald, Body Noémie, De Franco Valeria   +8 more
doaj   +1 more source

Assessment of tumor-infiltrating TCRVγ9Vδ2 γδ lymphocyte abundance by deconvolution of human cancers microarrays

OncoImmunology, 2017
Most human blood γδ cells are cytolytic TCRVγ9Vδ2+ lymphocytes with antitumor activity. They are currently investigated in several clinical trials of cancer immunotherapy but so far, their tumor infiltration has not been systematically explored across ...
Marie Tosolini, Frédéric Pont, Mary Poupot, François Vergez, Marie-Laure Nicolau-Travers, David Vermijlen, Jean- Emmanuel Sarry, Francesco Dieli, Jean-Jacques Fournié   +8 more
doaj   +1 more source

13-year survival oligometastatic Merkel cell carcinoma: a case report

Journal of Medical Case Reports
Background Merkel cell carcinomas are rare, aggressive skin tumors with high metastatic potential and poor prognosis. Their treatment is classically based on surgery with adjuvant external radiotherapy for localized tumors or on immunotherapy or ...
I. Trampetti, J. C. Faivre, L. Geoffrois, W. Gehin, S. Renard   +4 more
doaj   +1 more source

The French multicentric molecular analysis platforms and personalized medicine trials MOST, MOST Plus and MEGAMOST

Acta Oncologica
Background and purpose: In this manuscript we describe the academic French multicentric molecular analysis platforms including PROFILER, promoted by Centre Léon Berard, and the multicentric personalized medicine trials MOST, MOST Plus and MEGAMOST ...
Loic Verlingue, Marine Desevre, Marie Polito, Gwenaelle Garin, Christine Rodriguez, Wang Qing, Olivier Tredan, David Perol, Isabelle Ray-Coquard, Sylvie Chabaud, Jean Yves Blay   +10 more
doaj   +1 more source

Favourable long-term outcomes in selected HER2-Positive early breast cancer patients without pathological complete response after neoadjuvant chemotherapy and trastuzumab: A pre–T-DM1 era cohort study

Cancer Treatment and Research Communications
Background: Adjuvant trastuzumab emtansine (T-DM1) is the standard treatment for HER2-positive early breast cancer (EBC) patients who do not achieve a pathologic complete response (pCR) after neoadjuvant chemotherapy (NAC). Given the heterogeneity within
Ludovic Doucet, Camille Moreau-Bachelard, Laurent Mathiot, Olivier Kerdraon, Marie Robert, Julie Quintin, François Bocquet, Morgan Zenatri, Mario Campone, Jean-Sébastien Frenel   +9 more
doaj   +1 more source

EMT or EMT-promoting transcription factors, where to focus the light?

Frontiers in Oncology, 2014
Stéphane eAnsieau, Stéphane eAnsieau, Stéphane eAnsieau, Stéphane eAnsieau, Stéphane eAnsieau, Guillaume eCollin, Guillaume eCollin, Guillaume eCollin, Guillaume eCollin, Guillaume eCollin, Louise eHill, Louise eHill, Louise eHill, Louise eHill, Louise eHill   +14 more
doaj   +1 more source

Correction: Conditional generation of free radicals by selective activation of alkoxyamines: towards more effective and less toxic targeting of brain tumors. [PDF]

Chem Sci
Piris P, Buric D, Yamasaki T, Huchedé P, Rossi M, Matteudi M, Montero MP, Rodallec A, Appay R, Roux C, Combes S, Pasquier E, Castets M, André N, Brémond P, Carré M.   +15 more
europepmc   +1 more source

From relapse to survival: real-world clinical impact of a multimodal approach in first-time recurrent glioblastoma : FROST: multimodal treatment for GBM recurrence. [PDF]

J Neurooncol
Barbe-Richaud JB, Cebula H, Todeschi J, Santin MDN, Baloglu S, Schott R, Cotton M, Blouet A, Bobin M, Noël G, Somme L.   +10 more
europepmc   +1 more source

Sensorineural hearing loss after pediatric cranial radiotherapy: a multicenter analysis of dosimetric and clinical risk factors. [PDF]

Support Care Cancer
Gehin W, Ollivier L, Jouglar E, Dossun C, Jolnerovski M, Bernier-Chastagner V.   +5 more
europepmc   +1 more source